Assignee
OXFORD DRUG DESIGN LTD
GB·3 granted patents·0 citations·filing 2016–2020
Top patents by PatentIndex Score
3 records- 0143US11072581B2N-acyl-arylsulfonamide derivatives as aminoacyl-tRNA synthetase inhibitorsOXFORD DRUG DESIGN LTD·Filed 2016·Granted Jul 27, 2021·0 cites·19 claims
- 0237US12247004B22-amino-N-(amino-oxo-aryl-lambda6-sulfanylidene)acetamide compounds and their therapeutic useOXFORD DRUG DESIGN LTD·Filed 2020·Granted Mar 11, 2025·0 cites·24 claims
- 0335US11802110B22-amino-N-(arylsulfinyl)-acetamide compounds as inhibitors of bacterial aminoacyl-tRNA synthetaseOXFORD DRUG DESIGN LTD·Filed 2017·Granted Oct 31, 2023·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when OXFORD DRUG DESIGN LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →